Literature DB >> 10844873

The diabetic foot.

M B Tomas1, M Patel, S E Marwin, C J Palestro.   

Abstract

Foot complications in diabetics often lead to amputation. Ulceration is the most common complication in the diabetic forefoot and underlies more than 90% of cases of pedal osteomyelitis. The diagnosis of osteomyelitis is, nevertheless, difficult, and imaging is an important part of the work-up. Plain radiographs, although useful for anatomical information, are neither sensitive nor specific. Three-phase bone scintigraphy is sensitive but not specific. Labelled leucocyte scintigraphy and MRI are both useful and are complementary to one another. Labelled leucocyte scintigraphy is valuable for diagnosis as well as follow-up of pedal osteomyelitis. MRI offers exquisite anatomical detail, which is invaluable for guiding surgical management. The principal complication in the mid and hind foot is the neuropathic or Charcot joint. Although infection of the neuropathic joint is infrequent, its diagnosis is difficult. The extensive bony changes that accompany this disorder severely diminish the value of radiography and bone scintigraphy. It is not always possible to distinguish the marrow oedema of neuropathy from that of osteomyelitis and the role of MRI in the evaluation of this entity is still uncertain. Uptake of labelled leucocytes in the absence of infection may occur and is owing, at least in part, to haematopoietically active marrow. Combined leucocyte/marrow scintigraphy holds considerable promise for identifying the infected Charcot joint.

Entities:  

Mesh:

Year:  2000        PMID: 10844873     DOI: 10.1259/bjr.73.868.10844873

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  17 in total

1.  Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus.

Authors:  Virna Zampa; Irene Bargellini; Loredana Rizzo; Francesca Turini; Simona Ortori; Alberto Piaggesi; Carlo Bartolozzi
Journal:  Skeletal Radiol       Date:  2011-01-28       Impact factor: 2.199

2.  Is there a role for imaging in the management of patients with diabetic foot?

Authors:  Vartan M Vartanians; Adolf W Karchmer; John M Giurini; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2009-07       Impact factor: 2.199

3.  Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathy.

Authors:  Francesca Bolacchi; Luigi Uccioli; Salvatore Masala; Laura Giurato; Valeria Ruotolo; Marco Meloni; Eleonora Baffari; Elenia Cinelli; Marcello Cadioli; Ettore Squillaci; Giovanni Simonetti; Alberto Bergamini
Journal:  Eur Radiol       Date:  2013-06-11       Impact factor: 5.315

4.  Magnetic resonance imaging of diabetic foot complications.

Authors:  Keynes T A Low; Wilfred C G Peh
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

5.  An older patient with diabetes and severe foot pain.

Authors:  Gary Ross Farris; Starr Steinhilber
Journal:  CMAJ       Date:  2016-10-24       Impact factor: 8.262

6.  FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot.

Authors:  Olga Kagna; Saher Srour; Eyal Melamed; Daniela Militianu; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

7.  MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.

Authors:  Riccardo Marano; Dario Pitocco; Enrico Di Stasio; Giancarlo Savino; Biagio Merlino; Carlo Trani; Federica Pirro; Claudia Rutigliano; Carolina Santangelo; Aurelian Costin Minoiu; Luigi Natale; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 8.  Management of osteomyelitis of the foot in diabetes mellitus.

Authors:  Fran Game
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

9.  Midfoot and hindfoot bone marrow edema identified by magnetic resonance imaging in feet of subjects with diabetes and neuropathic ulceration is common but of unknown clinical significance.

Authors:  Chandani Thorning; Wladyslaw M W Gedroyc; Philippa A Tyler; Elizabeth A Dick; Elaine Hui; Jonathan Valabhji
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 17.152

10.  Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study.

Authors:  Dario Pitocco; Giovanni Zelano; Giuseppina Gioffrè; Enrico Di Stasio; Francesco Zaccardi; Francesca Martini; Tittania Musella; Giuseppe Scavone; Marco Galli; Salvatore Caputo; Lorena Mancini; Giovanni Ghirlanda
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.